 | Up a level |
Journal Article
Kremer, Andreas E., van Dijk, Remco, Leckie, Pamela, Schaap, Frank G., Kuiper, Edith M. M., Mettang, Thomas, Reiners, Katrin S., Raap, Ulrike, van Buuren, Henk R., van Erpecum, Karel J., Davies, Nathan A., Rust, Christian, Engert, Andreas, Jalan, Rajiv, Elferink, Ronald P. J. Oude and Beuers, Ulrich (2012). Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology, 56 (4). S. 1391 - 1401. HOBOKEN: WILEY. ISSN 1527-3350
Traussnigg, Stefan, Schattenberg, Jorn M. 
ORCID: 0000-0002-4224-4703, Demir, Muenevver, Wiegand, Johannes, Geier, Andreas, Teuber, Gerlinde, Hofmann, Wolf Peter, Kremer, Andreas E., Spreda, Frank, Kluwe, Johannes, Petersen, Joerg, Boettler, Tobias ORCID: 0000-0002-1195-055X, Halilbasic, Emina, Greinwald, Roland, Proels, Markus, Manns, Michael P., Fickert, Peter and Trauner, Michael H.
(2017).
norUrsodeoxycholic acid (norUDCA) improves non-alcoholic fatty liver disease (NAFLD): Results from a randomized placebo-controlled, double-blind phase IIa study.
Hepatology, 66.
S. 106A - 108.
HOBOKEN:
WILEY.
ISSN 1527-3350
Traussnigg, Stefan, Schattenberg, Jorn M. ORCID: 0000-0002-4224-4703, Demir, Munevver, Wiegand, Johannes, Geier, Andreas, Teuber, Gerfinde, Hofmann, Wolf Peter, Kremer, Andreas E., Spreda, Frank, Kluwe, Johannes, Petersen, Jorg, Boettler, Tobias ORCID: 0000-0002-1195-055X, Rainer, Florian, Halilbasic, Emina, Greinwald, Roland, Prols, Markus, Manns, Michael P., Fickert, Peter and Trauner, Michael ORCID: 0000-0002-1275-6425
(2019).
Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial.
Lancet Gastroenterol. Hepatol., 4 (10).
S. 781 - 794.
SAN DIEGO:
ELSEVIER INC.
ISSN 2468-1253